The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis
about
PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD.Selective peroxisome proliferator-activated receptor-α modulator K-877 efficiently activates the peroxisome proliferator-activated receptor-α pathway and improves lipid metabolism in mice.Hypertriglyceridaemia and risk of coronary artery disease.PPAR-α agonists are still on the rise: an update on clinical and experimental findings.Distinct but complementary contributions of PPAR isotypes to energy homeostasis.Dyslipidemias and Cardiovascular Prevention: Tailoring Treatment According to Lipid Phenotype.Pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor alpha modulator for management of atherogenic dyslipidaemia.Artery compliance in patients with rheumatoid arthritis: results from a case-control study.5-aminosalicylic acid improves lipid profile in mice fed a high-fat cholesterol diet through its dual effects on intestinal PPARγ and PPARα.Pemafibrate: First Global Approval.A Novel Selective PPARα Modulator (SPPARMα), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in Mice.The Role of PPAR and Its Cross-Talk with CAR and LXR in Obesity and Atherosclerosis.
P2860
Q30241952-DD25B09D-B04E-4568-9FA3-DEF28D914842Q39022770-6BB38584-E3EB-4085-9A57-362D43CAD328Q39181612-67BF9EA9-3263-49D4-ACFD-8E493B488397Q39200940-89569912-C909-455F-BA04-FA8649EA7367Q39214885-FA6FED44-0B98-404D-A318-8EDCDBF27FFEQ39320394-76E6D3F7-B458-4CF9-898C-A6E8BB071B6EQ42278957-00014FC0-D60B-4CC3-A383-4637013B4EABQ47602822-AD5CE0BE-1FBB-4DE6-B2C4-68C11664C3D6Q48203795-5580E344-04AB-422F-AD2E-8B603A51976DQ50001874-7E41569A-B27E-43EE-9CB7-ACC152CB62A7Q50320306-0DEEFB6F-EFF0-453C-8AE3-FF9C27FD5649Q54988933-5C2B7301-D5C8-4107-B079-121FB03C4054
P2860
The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis
description
im Juni 2016 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2016
@uk
name
The novel selective PPARα modu ...... flammation and atherosclerosis
@en
The novel selective PPARα modu ...... flammation and atherosclerosis
@nl
type
label
The novel selective PPARα modu ...... flammation and atherosclerosis
@en
The novel selective PPARα modu ...... flammation and atherosclerosis
@nl
prefLabel
The novel selective PPARα modu ...... flammation and atherosclerosis
@en
The novel selective PPARα modu ...... flammation and atherosclerosis
@nl
P2093
P50
P921
P1433
P1476
The novel selective PPARα modu ...... flammation and atherosclerosis
@en
P2093
Charlotte Paquet
Eloise Woitrain
Emmanuelle Vallez
Isabelle Duplan
Jonathan Vanhoutte
Philippe Lefebvre
Sophie Colin
Véronique Touche
P304
P356
10.1016/J.ATHEROSCLEROSIS.2016.03.003
P577
2016-06-01T00:00:00Z